Role of density of prostate-specific antigen transitory zone in early diagnosis of prostate cancer
Topuzov, M.E.
Voprosy Onkologii 53(3): 295-297
2007
ISSN/ISBN: 0507-3758 PMID: 18198610 Document Number: 612345
The paper discusses the 5-year results of early diagnosis of prostate cancer using prostate-specific antigen density and prostate-specific antigen transitory zone density, which improves differential diagnosis efficiency.
Document emailed within 1 workday
Related Documents
De la Taille, A.; Houlgatte, A.; Houdelette, P.; Berlizot, P.; Ramirez, J.; Ricordel, I. 1997: Value of free/total prostate specific antigen in the early diagnosis of prostate cancer (study of 105 patients) Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(2): 240-245Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Rahardjo, D.; Kamil, S.T.; Pakasi, L.S. 2000: Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 563-570
Galić, J.; Karner, I.; Cenan, L.; Tucak, A.; Hegedus, I.; Pasini, J.; Bilandzija-Peranović, M.; Mihaljević, S. 2003: Comparison of digital rectal examination and prostate specific antigen in early detection of prostate cancer Collegium Antropologicum 27(Suppl 1): 61-66
Bostwick, D.G. 1994: Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer American Journal of Clinical Pathology 102(4 Suppl 1): S31-S37
Hardeman, S.W.; Wake, R.W.; Soloway, M.S. 1989: Two new techniques for evaluating prostate cancer. The role of prostate-specific antigen and transrectal ultrasound Postgraduate Medicine 86(2): 197-8 201 204 Passim
Jung, P.; Wolff, J.M.; Mattelaer, P.; Jakse, G. 1996: Prostate specific antigen in the diagnosis and staging of prostate cancer Acta Urologica Belgica 64(3): 1-6
Rigaud, J.ér.ôm.; Bouchot, O. 2003: Prostate specific antigen and diagnosis of prostate cancer La Revue du Praticien 53(20): 2229-2236
Martin, A.A.; Clejan, S. 1994: Prostate specific antigen density: a method for differentiating prostate carcinoma from benign prostatic hypertrophy demonstrates ethnic variation Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 146(4): 163-171
Stenman, U.H.; Leinonen, J.; Alfthan, H.; Rannikko, S.; Tuhkanen, K.; Alfthan, O. 1991: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer Cancer Research 51(1): 222-226
Wu, C.T.; Chuang, C.K.; Chou, C.C.; Chu, S.H.; Chen, H.W.; Chen, C.S.; Chiang, Y.J.; Liao, S.K. 2000: The role of free to total prostate-specific antigen ratio for prostate cancer in screening patients with total serum levels between 4 and 20 ng/ml Chang Gung Medical Journal 23(3): 142-148
Goncalves, F.; Hornák, M.; Miklosi, M. 1997: Will determination of prostate specific antigen density improve the diagnosis of prostatic carcinoma? Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 76(9): 421-424
Bentvelsen, F.M.; Bogdanowicz, J.F.; Oosterom, R.; Schröder, F.H. 1990: A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma Nederlands Tijdschrift Voor Geneeskunde 134(33): 1596-1600
Cerović, S.; Dimitrijević, J.; Milović, N.; Ajdinović, B.; Knezević-Usaj, S.; Popović, L.; Brajusković, G. 2002: Prostate-specific antigen in the diagnosis and treatment of carcinoma of the prostate Vojnosanitetski Pregled 59(6 Suppl): 53-57
Fornara, P.; Sturm, W.; Fabricius, P.G.; Schmiedt, E. 1987: Clinical relevance of radioimmunologic determination of prostate specific antigen in prostate cancer Der Urologe. Ausg. a 26(3): 158-161
Wang, W.; Mo, Z.-N. 2010: Advances in prostate-specific membrane antigen targeted therapies for prostate cancer Zhonghua Nan Ke Xue 16(6): 547-551
Kelly, W.K.; Slovin, S.; Scher, H.I. 1996: Clinical use of posttherapy prostate-specific antigen changes in advanced prostate cancer Seminars in Oncology 23(6 Suppl 14: 8-14
Schäfer, U.; Micke, O.; Hampel, G.; Brandt, B.; Bovenschulte, A.; Semjonow, A.; Willich, N. 1997: The use of prostate-specific antigen (PSA) for the monitoring of radiation therapy in prostate cancer Anticancer Research 17(4b): 2983-2986
Serdar, M.A.; Oguz, O.; Olgun, A.; Seçkin, B.; Ilgan, S.; Hasimi, A.; Salih, M.; Peker, F.; Kutluay, T. 2002: Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together Annals of Clinical and Laboratory Science 32(1): 22-30
Maeda, H.; Arai, Y.; Ishitoya, S.; Okubo, K.; Aoki, Y.; Okada, T.; Maekawa, S. 1998: Free-to-total prostate specific antigen ratio in clinical staging of prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 44(5): 307-311